• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday

    9/2/22 5:29:22 AM ET
    $AGIO
    $AI
    $AMD
    $AVCT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $AGIO alert in real time by email

    Gainers

    • Hempacco Co., Inc. (NASDAQ:HPCO) shares jumped 63.4% to close at $8.35 after dropping 34% on Wednesday. Hempacco's common shares began trading on the Nasdaq Tuesday. The company had planned to offer 1 million shares of common stock at a public offering price of $6 per share for total gross proceeds of $6 million.
    • GigaCloud Technology Inc. (NASDAQ:GCT) climbed 61.4% to close at $23.65.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) surged 58.7% to settle at $5.57.
    • Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) jumped 51% to close at $20.24 after Novo Nordisk announced it will acquire the company for $20 per share in cash.
    • ShiftPixy, Inc. (NASDAQ:PIXY) surged 46.9% to close at $20.58 on Thursday. ShiftPixy announced a 1-for-100 reverse stock split.
    • Shuttle Pharmaceuticals, Inc. (NASDAQ:SHPH) shares surged 36.2% to close at $52.40 amid post-IPO volatility. The company priced its IPO at $8.125 per unit.
    • Kuke Music Holding Limited (NYSE:KUKE) jumped 32.9% to close at $1.13.
    • Nutanix, Inc. (NASDAQ:NTNX) gained 29.1% to close at $22.34 after the company reported better-than-expected sales results for its fourth quarter and issued strong revenue forecast.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) climbed 28.6% to close at $0.3060. InMed Pharmaceuticals recently announced a 1:25 share consolidation to meet Nasdaq listing criteria.
    • Eyenovia, Inc. (NASDAQ:EYEN) gained 25.2% to settle at $2.04.
    • Twin Disc, Incorporated (NASDAQ:TWIN) jumped 24.6% to close at $11.59 after the company posted a profit for the fourth quarter.
    • Immuneering Corporation (NASDAQ:IMRX) rose 24.6% to settle at $6.95.
    • Immuneering, last month, posted a Q2 loss of $0.44 per share.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) gained 23.2% to close at $2.18 after the company announced it has entered into a purchase agreement with Arena Business Solutions for up to $15 million of the company's common stock.
    • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) jumped 22.4% to close at $4.75.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) rose 22.4% to close at $3.01.
    • Purple Innovation, Inc. (NASDAQ:PRPL) jumped 20.3% to settle at $3.44 after the company announced the acquisition of Intellibed.
    • Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) gained 20% to close at $30.59. Agios Pharmaceuticals, last month, reported better-than-expected Q2 EPS and sales results.
    • Werewolf Therapeutics, Inc. (NASDAQ:HOWL) jumped 19.6% to settle at $6.05. Werewolf Therapeutics initiated patient dosing in a Phase 1/1b clinical trial evaluating WTX-124, its lead INDUKINET molecule targeting IL-2 for the treatment of solid tumors.
    • RiceBran Technologies (NASDAQ:RIBT) gained 18.6% to close at $2.74. The company, last month, posted upbeat quarterly sales.
    • PaxMedica, Inc. (NASDAQ:PXMD) climbed 18.2% to close at $3.50. PaxMedica Executive Chairman, Director Michael Derby reported in Form4 filing purchase of 95,000 shares at $5.25 per share.
    • Belite Bio, Inc (NASDAQ:BLTE) jumped 14.3% to close at $36.70. Belite Bio recently announced it has commenced enrollment for the US Phase 3 clinical trial of LBS-008 in patients with Stargardt Disease.
    • Turquoise Hill Resources Ltd. (NYSE:TRQ) rose 13.9% to close at $31.30. Rio Tinto Group announced plans to acquire full ownership of Turquoise Hill Resources for C$43 per share in cash.
    • Bright Green Corporation (NASDAQ:BGXX) shares rose 12.3% to close at $1.55 after gaining around 33% on Wednesday.
    • Bausch Health Companies Inc. (NYSE:BHC) gained 10.4% to close at $6.59. RBC Capital maintained Bausch Health Companies with a Sector Perform and raised the price target from $4.5 to $8.
    • Relay Therapeutics, Inc. (NASDAQ:RLAY) climbed 8.4% to settle at $24.90. Stifel initiated coverage on Relay Therapeutics with a Buy rating and announced a price target of $40 today.
    • DXC Technology Company (NYSE:DXC) gained 7.8% to settle at $26.70.
    • Snap Inc. (NYSE:SNAP) jumped 7% to close at $11.64 after multiple analysts raised their price targets on the stock. The company on Wednesday announced restructuring plans and a workforce reduction.
    • Five Below, Inc. (NASDAQ:FIVE) rose 6.3% to close at $135.92 after the company reported Q2 earnings results.


    Losers

    • Addentax Group Corp. (NASDAQ:ATXG) shares dropped 95.4% to close at $30.00 following the company's uplisting and IPO.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) dipped 52.2% to settle at $0.2200 after the company announced an equity distribution agreement to offer and sell up to $14.7 million shares of common stock.
    • NewAge, Inc. (NYSE:NBEV) dropped 46.9% to settle at $0.1222 on continued weakness after the company recently announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code.
    • Okta, Inc. (NASDAQ:OKTA) declined 33.7% to close at $60.60 after the company reported Q2 earnings results and issued Q3 and FY23 financial guidance. Several analysts also lowered their price targets on the stock.
    • Getty Images Holdings, Inc. (NYSE:GETY) fell 28.8% to close at $14.42.
    • Semtech Corporation (NASDAQ:SMTC) shares fell 27.2% to close at $33.65 after the company issued Q3 sales guidance below analyst estimates. Cowen & Co. and Oppenheimer also downgraded the stock.
    • Nogin, Inc. (NASDAQ:NOGN) dropped 25.7% to close at $2.5050.
    • MongoDB, Inc. (NASDAQ:MDB) shares fell 25.3% to close at $241.11 after the company issued earnings guidance below analyst estimates.
    • Greenpro Capital Corp. (NASDAQ:GRNQ) fell 24.8% to close at $1.91 after surging 63% on Wednesday.
    • Hour Loop, Inc. (NASDAQ:HOUR) dipped 24.7% to close at $3.20.
    • Rain Therapeutics Inc. (NASDAQ:RAIN) declined 19.9% to close at $4.75.
    • C3.ai, Inc. (NYSE:AI) fell 19.3% to close at $14.52 after the company reported worse-than-expected Q1 sales results and issued Q3 and FY23 sales guidance below analyst estimates.
    • Blackboxstocks Inc. (NASDAQ:BLBX) dropped 19.3% to settle at $0.96.
    • Codiak BioSciences, Inc. (NASDAQ:CDAK) declined 19.1% to settle at $1.74 after Goldman Sachs downgraded the stock from Buy to Neutral and lowered its price target from $6 to $2.
    • Akerna Corp. (NASDAQ:KERN) dipped 19% to settle at $0.1248.
    • Genesco Inc. (NYSE:GCO) fell 18.4% to close at $46.16 as the company lowered FY23 forecast.
    • NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) declined 18% to close at $2.09.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) dropped 17.2% to settle at $1.59.
    • Nuwellis, Inc. (NASDAQ:NUWE) fell 16.4% to close at $1.22. Nuwellis shares jumped 121% on Wednesday after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in high-risk postoperative coronary artery bypass grafting patients.
    • Magic Empire Global Limited (NASDAQ:MEGL) dipped 16% to close at $6.53 after surging 33% on Wednesday.
    • Liquidia Corporation (NASDAQ:LQDA) fell 15.8% to close at $4.86 after Wedbush downgraded the stock from Neutral to Underperform and lowered its price target from $4 to $3.
    • GitLab Inc. (NASDAQ:GTLB) dipped 15.6% to close at $50.53.
    • Lands' End, Inc. (NASDAQ:LE) declined 15.3% to settle at $11.70 after the company issued Q3 EPS and sales and FY22 EPS guidance below estimates.
    • HashiCorp, Inc. (NASDAQ:HCP) fell 14.4% to close at $30.26.
    • Palatin Technologies, Inc. (NYSE:PTN) declined 14.3% to close at $4.30.
    • Veeva Systems Inc. (NYSE:VEEV) fell 14% to settle at $171.42 after the company issued Q3 and FY23 sales guidance below analyst estimates.
    • Mobilicom Limited (NASDAQ:MOB) declined 13.8% to close at $2.69 after gaining around 28% on Wednesday.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) shares fell 13.8% to close at $5.55 after surging around 19% on Wednesday.
    • Samsara Inc. (NYSE:IOT) fell 13% to close at $12.94 following Q3 results.
    • Signet Jewelers Limited (NYSE:SIG) fell 12% to close at $57.50 following Q2 results.
    • Polestar Automotive Holding UK PLC (NASDAQ:PSNY) fell 11.9% to close at $6.89. Polestar reported H1 sales of $1.04 billion.
    • Ciena Corporation (NYSE:CIEN) dipped 10.4% to settle at $45.48 after the company reported worse-than-expected Q3 sales results.
    • Enovix Corporation (NASDAQ:ENVX) declined 10% to close at $19.92.
    • Vicor Corporation (NASDAQ:VICR) fell 10% to settle at $64.05.
    • Fluence Energy, Inc. (NASDAQ:FLNC) fell 9.6% to close at $18.03.
    • KnowBe4, Inc. (NASDAQ:KNBE) declined 9.6% to close at $17.37.
    • DigitalOcean Holdings, Inc. (NASDAQ:DOCN) fell 8.9% to close at $38.33.
    • Zscaler, Inc. (NASDAQ:ZS) fell 8.6% to close at $145.57.
    • Stem, Inc. (NYSE:STEM) declined 8.4% to close at $14.40.
    • NVIDIA Corporation (NASDAQ:NVDA) fell 7.7% to close at $139.37 following a late Wednesday filing by the company that revealed that the U.S. government has communicated to it the need to secure a license for exporting its powerful AI processors such as the A100 and the yet-to-be-released H100 chips to China. This would prevent the export of these chips to China, one of its key markets.
    • Smartsheet Inc. (NYSE:SMAR) fell 7.4% to close at $30.82.
    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) fell 7% to close at $0.2284 after gaining 11% on Wednesday. ThermoGenesis, last month, posted a Q2 loss of $0.20 per share.
    • Hormel Foods Corporation (NYSE:HRL) fell 6.6% to close at $46.98 after the company posted downbeat Q3 earnings and lowered FY22 earnings forecast.
    • Monolithic Power Systems, Inc. (NASDAQ:MPWR) dipped 6.1% to close at $425.47.
    • SentinelOne, Inc.(NYSE:S) fell 5.9% to close at $25.70 after reporting Q2 results.
    • HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE) fell 4.7% to close at $4.85 after gaining 4% on Wednesday.
    • Advanced Micro Devices, Inc (NASDAQ:AMD) fell 3% to close at $82.33 following news that the chipmakers were slapped with certain chip export restrictions to China.
    Get the next $AGIO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGIO
    $AI
    $AMD
    $AVCT

    CompanyDatePrice TargetRatingAnalyst
    Samsara Inc.
    $IOT
    2/11/2026$36.00Buy
    Goldman
    Snap Inc.
    $SNAP
    2/10/2026$7.30Neutral → Buy
    Arete
    Fluence Energy Inc.
    $FLNC
    2/10/2026$24.00Hold → Buy
    Jefferies
    Snap Inc.
    $SNAP
    2/6/2026$5.50Sell → Hold
    Stifel
    Snap Inc.
    $SNAP
    2/5/2026$10.00Neutral → Buy
    BofA Securities
    DigitalOcean Holdings Inc.
    $DOCN
    2/5/2026$68.00Neutral → Overweight
    Cantor Fitzgerald
    Five Below Inc.
    $FIVE
    2/4/2026$233.00Underperform → Buy
    BofA Securities
    HIVE Digital Technologies Ltd.
    $HIVE
    1/27/2026$3.50Outperform → Mkt Perform
    Keefe Bruyette
    More analyst ratings

    $AGIO
    $AI
    $AMD
    $AVCT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

    For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

    11/9/23 2:30:20 PM ET
    $SRAX
    $SNAP
    Advertising
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $AGIO
    $AI
    $AMD
    $AVCT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HIVE Digital Technologies to Release Fiscal Q3 2026 Financial Results and Hold Earnings Call on February 17

    San Antonio, Texas,--(Newsfile Corp. - February 12, 2026) - HIVE Digital Technologies Ltd. (TSXV:HIVE) (NASDAQ:HIVE) (FSE: YO0) (BVC: HIVECO) (the "Company" or "HIVE"), a diversified global leader in renewable-powered blockchain and AI infrastructure, today announced it will release its financial results for the nine months ended December 31, 2025 on Tuesday, February 17, 2026, followed by an earnings conference call and webcast on Tuesday, February 17, 2026, at 8:00 AM EST.Conference Call InformationTo participate in this event, please log on or dial in approximately 5 minutes before the call.Date: February 17, 2026Time: 8:00 AM EST Webcast: Registration link here. Dial-in: Provided after r

    2/12/26 1:00:00 AM ET
    $HIVE
    Finance: Consumer Services
    Finance

    Veeva to Release Fiscal 2026 Fourth Quarter and Full Year Results on March 4, 2026

    PLEASANTON, Calif., Feb. 11, 2026 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its fourth quarter and full fiscal year, which ended January 31, 2026, after market close on March 4, 2026. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at ir.veeva.com at approximately 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva Systems' Fiscal 2026 Fourth Quarter and Full Year Results Conference Call Date: Wednesday, March 4, 2026 Time: 2:00 p.m. PT (5:00 p.m. ET) Co

    2/11/26 4:05:00 PM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    Enovix to Release Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    FREMONT, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Enovix Corporation (NASDAQ:ENVX) ("Company" or "Enovix"), a global high-performance battery company, today announced it will release financial results for the fourth quarter and full year 2025 on Wednesday, February 25, 2026, after the close of the market. Enovix will hold a live video call at 2:00 PM PT / 5:00 PM ET on February 25, 2026, to discuss the company's business updates, key milestones, and financial results. To join the call, participants must use the following link to register: https://enovix-q4-2025.open-exchange.net/.  This link will also be available via the Investor Relations section of Enovix's website at https://ir.enovi

    2/11/26 8:30:00 AM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    $AGIO
    $AI
    $AMD
    $AVCT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Fernandez Raul J bought $250,706 worth of shares (16,446 units at $15.24), increasing direct ownership by 2% to 816,001 units (SEC Form 4)

    4 - DXC Technology Co (0001688568) (Issuer)

    2/3/26 5:55:04 PM ET
    $DXC
    EDP Services
    Technology

    Chief Business Officer Brakewood Harold Eugene bought $24,990 worth of shares (5,250 units at $4.76), increasing direct ownership by 91% to 11,050 units (SEC Form 4)

    4 - Immuneering Corp (0001790340) (Issuer)

    1/21/26 9:09:57 AM ET
    $IMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Schall Thomas J. bought $101,041 worth of shares (21,645 units at $4.67), increasing direct ownership by 41% to 74,530 units (SEC Form 4)

    4 - Immuneering Corp (0001790340) (Issuer)

    1/20/26 9:17:29 AM ET
    $IMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIO
    $AI
    $AMD
    $AVCT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Samsara with a new price target

    Goldman initiated coverage of Samsara with a rating of Buy and set a new price target of $36.00

    2/11/26 7:52:47 AM ET
    $IOT
    EDP Services
    Technology

    Snap upgraded by Arete with a new price target

    Arete upgraded Snap from Neutral to Buy and set a new price target of $7.30

    2/10/26 7:58:39 AM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    Fluence upgraded by Jefferies with a new price target

    Jefferies upgraded Fluence from Hold to Buy and set a new price target of $24.00

    2/10/26 7:57:53 AM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    $AGIO
    $AI
    $AMD
    $AVCT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lee Victor K sold $484,864 worth of shares (400 units at $1,212.16), decreasing direct ownership by 1% to 27,756 units (SEC Form 4)

    4 - MONOLITHIC POWER SYSTEMS INC (0001280452) (Issuer)

    2/11/26 6:44:43 PM ET
    $MPWR
    Semiconductors
    Technology

    President and CEO Batten John H gave a grant of 30,000 shares, decreasing direct ownership by 2% to 485,434 units (SEC Form 4)

    4 - TWIN DISC INC (0000100378) (Issuer)

    2/11/26 6:33:32 PM ET
    $TWIN
    Industrial Machinery/Components
    Industrials

    VP Finance, CFO, Secr & Trea Knutson Jeffrey Scott gave a grant of 4,108 shares, decreasing direct ownership by 2% to 171,664 units (SEC Form 4)

    4 - TWIN DISC INC (0000100378) (Issuer)

    2/11/26 6:33:01 PM ET
    $TWIN
    Industrial Machinery/Components
    Industrials

    $AGIO
    $AI
    $AMD
    $AVCT
    SEC Filings

    View All

    SEC Form 10-Q filed by InMed Pharmaceuticals Inc.

    10-Q - InMed Pharmaceuticals Inc. (0001728328) (Filer)

    2/11/26 5:04:01 PM ET
    $INM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Werewolf Therapeutics Inc.

    SCHEDULE 13G/A - Werewolf Therapeutics, Inc. (0001785530) (Subject)

    2/11/26 3:46:02 PM ET
    $HOWL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Samsara Inc.

    SCHEDULE 13G/A - Samsara Inc. (0001642896) (Subject)

    2/10/26 11:00:58 AM ET
    $IOT
    EDP Services
    Technology

    $AGIO
    $AI
    $AMD
    $AVCT
    Leadership Updates

    Live Leadership Updates

    View All

    AMD Hires Ariel Kelman as Chief Marketing Officer

    SANTA CLARA, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Today AMD (NASDAQ:AMD) announced that Ariel Kelman has been appointed Senior Vice President and Chief Marketing Officer, effective immediately. Kelman will lead the AMD global marketing organization, overseeing brand, communications, events, developer relations and go-to-market strategy. Kelman will report to Ruth Cotter, Senior Vice President and Chief Administrative Officer, and will work closely with the AMD executive team to deepen engagement with customers, partners, developers and the broader technology ecosystem as AMD continues to scale its product and solutions leadership. "Ariel is a proven marketing leader with deep experi

    2/9/26 2:00:00 PM ET
    $AMD
    Semiconductors
    Technology

    Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target REalloys, to Appoint General Jack Keane to its Board of Directors

    General Keane, a Four-Star General (Ret), Joins REalloys on its Mission to Scale North-America's Most Advanced Heavy Rare Earth Supply Chain & Technology Platform REalloys' Form S-4 has been declared effective by the SEC, and, pending NASDAQ listing approval, the company expects to close its merger with Blackboxstocks, Inc. (NASDAQ:BLBX) DALLAS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ:BLBX) ("Blackboxstocks" or the "Company") today announced that its merger target, REalloys Inc. ("REalloys"), has appointed General John M. "Jack" Keane (U.S. Army, Ret.) as a Designate Director. General Keane will formally join the Board of Directors upon the closing of the merger b

    2/9/26 8:30:00 AM ET
    $BLBX
    EDP Services
    Technology

    Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600

    NEW YORK, Feb. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600:  S&P MidCap 400 constituent Ciena Corp. (NYSE:CIEN) will replace Dayforce Inc. (NYSE:DAY) in the S&P 500, S&P SmallCap 600 constituent Arrowhead Pharmaceuticals Inc. (NASD: ARWR) will replace Ciena in the S&P MidCap 400, and ADT Inc. (NYSE:ADT) will replace Arrowhead Pharmaceuticals in the S&P SmallCap 600 effective prior to the opening of trading on Monday, February 9. Thoma Bravo L.P. acquired Dayforce in a deal that closed today.OneSpaWorld Holdings Ltd. (NASD: OSW) will replace Dynavax Technologies Corp. (NASD: DVAX) in the S&P SmallCap 600 effec

    2/4/26 6:15:00 PM ET
    $ADT
    $ARWR
    $CIEN
    Diversified Commercial Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIO
    $AI
    $AMD
    $AVCT
    Financials

    Live finance-specific insights

    View All

    HIVE Digital Technologies to Release Fiscal Q3 2026 Financial Results and Hold Earnings Call on February 17

    San Antonio, Texas,--(Newsfile Corp. - February 12, 2026) - HIVE Digital Technologies Ltd. (TSXV:HIVE) (NASDAQ:HIVE) (FSE: YO0) (BVC: HIVECO) (the "Company" or "HIVE"), a diversified global leader in renewable-powered blockchain and AI infrastructure, today announced it will release its financial results for the nine months ended December 31, 2025 on Tuesday, February 17, 2026, followed by an earnings conference call and webcast on Tuesday, February 17, 2026, at 8:00 AM EST.Conference Call InformationTo participate in this event, please log on or dial in approximately 5 minutes before the call.Date: February 17, 2026Time: 8:00 AM EST Webcast: Registration link here. Dial-in: Provided after r

    2/12/26 1:00:00 AM ET
    $HIVE
    Finance: Consumer Services
    Finance

    Veeva to Release Fiscal 2026 Fourth Quarter and Full Year Results on March 4, 2026

    PLEASANTON, Calif., Feb. 11, 2026 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its fourth quarter and full fiscal year, which ended January 31, 2026, after market close on March 4, 2026. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at ir.veeva.com at approximately 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva Systems' Fiscal 2026 Fourth Quarter and Full Year Results Conference Call Date: Wednesday, March 4, 2026 Time: 2:00 p.m. PT (5:00 p.m. ET) Co

    2/11/26 4:05:00 PM ET
    $VEEV
    Computer Software: Prepackaged Software
    Technology

    Enovix to Release Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    FREMONT, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Enovix Corporation (NASDAQ:ENVX) ("Company" or "Enovix"), a global high-performance battery company, today announced it will release financial results for the fourth quarter and full year 2025 on Wednesday, February 25, 2026, after the close of the market. Enovix will hold a live video call at 2:00 PM PT / 5:00 PM ET on February 25, 2026, to discuss the company's business updates, key milestones, and financial results. To join the call, participants must use the following link to register: https://enovix-q4-2025.open-exchange.net/.  This link will also be available via the Investor Relations section of Enovix's website at https://ir.enovi

    2/11/26 8:30:00 AM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    $AGIO
    $AI
    $AMD
    $AVCT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by SentinelOne Inc.

    SC 13D/A - SentinelOne, Inc. (0001583708) (Subject)

    12/12/24 6:30:27 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Samsara Inc.

    SC 13D/A - Samsara Inc. (0001642896) (Subject)

    12/11/24 9:27:25 PM ET
    $IOT
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Eyenovia Inc.

    SC 13D/A - EYENOVIA, INC. (0001682639) (Subject)

    12/4/24 4:12:20 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care